Cargando…
Sex Hormone-Binding Globulin (SHBG) in Cerebrospinal Fluid Does Not Discriminate between the Main FTLD Pathological Subtypes but Correlates with Cognitive Decline in FTLD Tauopathies
Biomarkers to discriminate the main pathologies underlying frontotemporal lobar degeneration (FTLD-Tau, FTLD-TDP) are lacking. Our previous FTLD cerebrospinal fluid (CSF) proteome study revealed that sex hormone-binding globulin (SHBG) was specifically increased in FTLD-Tau patients. Here we investi...
Autores principales: | del Campo, Marta, Pijnenburg, Yolande A. L., Chen-Plotkin, Alice, Irwin, David J., Grossman, Murray, Twaalfhoven, Harry A. M., Hu, William T., Meeter, Lieke H., van Swieten, John, Vermunt, Lisa, Martens, Frans, Heijboer, Annemieke C., Teunissen, Charlotte E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533538/ https://www.ncbi.nlm.nih.gov/pubmed/34680117 http://dx.doi.org/10.3390/biom11101484 |
Ejemplares similares
-
Novel CSF biomarkers to discriminate FTLD and its pathological subtypes
por: del Campo, Marta, et al.
Publicado: (2018) -
Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies
por: Keszycki, Rachel, et al.
Publicado: (2023) -
Detecting clinical change with the CDR‐FTLD: differences between FTLD and AD dementia
por: Mioshi, Eneida, et al.
Publicado: (2016) -
Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors
por: Fiondella, Luigi, et al.
Publicado: (2023) -
Tau immunotherapy is associated with glial responses in FTLD-tau
por: Kim, Boram, et al.
Publicado: (2021)